Cannabis Sativa, Inc. (CBDS)
| Market Cap | 23.62M |
| Revenue (ttm) | 2.13M |
| Net Income (ttm) | -3.84M |
| Shares Out | 25.76M |
| EPS (ttm) | -0.16 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | March 4 |
| Last Price | $0.7530 |
| Previous Close | $0.8700 |
| Change ($) | -0.1170 |
| Change (%) | -13.45% |
| Day's Open | 0.8650 |
| Day's Range | 0.7500 - 0.8699 |
| Day's Volume | 218,074 |
| 52-Week Range | 0.32 - 1.25 |
News
There are no news available yet.
About CBDS
Cannabis Sativa, through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. It operates through three divisions: Telemedicine, Contract Manufacturing, and Brand Development and Product Marketing. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology; and operates as a contract manufacturer of products containing hemp-based c... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | |
| CEO David Tobias | Employees 12 |
| Stock Exchange OTCMKTS | Ticker Symbol CBDS |
Financial Performance
In 2019, CBDS's revenue was $1.16 million, an increase of 129.33% compared to the previous year's $505,705. Losses were -$3.94 million, -4.65% less than in 2018.